Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Agrees to Buy CambridgeSoft, Completes ArtusLabs Purchase

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – PerkinElmer today announced two acquisitions totaling $220 million in aggregate to expand its informatics and software offerings and enable customers to access and share enterprise-wide data "for faster, more informed scientific decisions."

The Waltham, Mass.-based firm has signed a definitive agreement to acquire CambridgeSoft in one deal and completed its purchase of ArtusLabs in the other. The CambridgeSoft acquisition is expected to close in the second quarter.

CambridgeSoft, headquartered in Cambridge, Mass., provides discovery, collaboration, and knowledge enterprise solutions, scientific databases, and professional services primarily to the pharmaceutical, biotechnology, and chemical industries.

ArtusLabs is based in the Research Triangle Park area in North Carolina and provides software solutions to pharma and related industries. Its flagship product, the Ensemble platform, integrates data from customer electronic laboratory notebooks and informatics systems and databases to drive the research process.

"CambridgeSoft brings strong customer relationships and excellent organizational capability, along with market leading products in both desktop and enterprise-wide software," Robert Friel, chairman and CEO of PerkinElmer, said in a statement. "ArtusLabs provides us with innovative technology enabling enhanced access to scientific knowledge and is highly complementary to CambridgeSoft's informatics solution."

For full-year 2011, CambridgeSoft and ArtusLabs are expected to generate about $65 million in aggregate revenues, PerkinElmer said. In addition to the $220 million purchase price, PerkinElmer could pay up to $15 million in contingent fees.

The deal is expected dilute PerkinElmer's 2011 GAAP earnings per share by $.13. On a non-GAAP basis, PerkinElmer anticipates the deal to be accretive to its adjusted EPS by about $.04.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.